This is an auto-generated stub page built from atlas entry frontmatter. A richer
hand-crafted page is planned. See the
atlas source
for the full entry including detailed body sections.
npm1
NPM1
NPM1 (nucleophosmin) exon 12 insertions create cytoplasmic NPM1c in ~30% AML; NPM1c sequesters ARF → reduced p53 activity; NPM1c AML is a WHO-defined entity with favorable prognosis if FLT3-ITD negative; NPM1 mRNA is a sensitive MRD marker by RT-qPCR.
Entry Metadata
| Field | Value |
|---|---|
| ID | npm1 |
| Name | NPM1 |
| Status | draft |
| Last reviewed | 2026-06-06 |
| Atlas | 01-human |
| Scale | 03-molecular |
Cross-Atlas Connections
Sources
- Falini B, Mecucci C, Tiacci E, et al. Cytoplasmic nucleophosmin in acute myelogenous leukemia with a normal karyotype. N Engl J Med. 2005;352(3):254-266. · PubMed 15659725
- Ivey A, Hills RK, Simpson MA, et al. Assessment of minimal residual disease in standard-risk AML. N Engl J Med. 2016;374(5):422-433. · PubMed 26789727